## FCX: Freeport-McMoRan Inc. - XLB: Basic Materials

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 7.0% in mid entry zone (4.0-10.0%), top 1% cross-sectional ranking. Caution: MRS_5 (-0.5%) diverging from MRS_20, watch for reversal. Outperforming sector by 5.1%. Caution: momentum weakening (-4.5% MRS), overbought RSI (71).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($48.42)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 2, Bearish: 7)

**1. Freeport-McMoRan stock today: FCX edges up as copper rebounds toward record highs**
- Source: ts2.tech | 20251230T194221 | Bullish | Relevance: 100%
- Freeport-McMoRan (FCX) shares rose about 0.5% as copper prices rebounded, with futures climbing after a previous session drop and remaining near year-end highs. The stock's performance is closely tied to copper prices, and the metal's year-end rally highlights supply tightness and demand from electrification and data centers. Traders are now watching whether copper can maintain these record levels into the new year, with inventories and Chinese demand as key factors.

**2. Deadline Alert: Freeport-McMoran Inc. (FCX) Shareholders**
- Source: GlobeNewswire | 20251230T170820 | Bearish | Relevance: 100%
- Glancy Prongay & Murray LLP is reminding investors of the January 12, 2026 deadline to file as a lead plaintiff in a class action lawsuit against Freeport-McMoran Inc. The lawsuit alleges that Freeport-McMoran made false and misleading statements and failed to disclose critical safety issues at its Grasberg Block Cave mine in Indonesia, leading to significant stock price drops after incidents. Investors who purchased FCX securities between February 15, 2022, and September 24, 2025, and suffered losses, are urged to contact the firm.

**3. Deadline Alert: Freeport-McMoran Inc. (FCX) Shareholders**
- Source: GlobeNewswire | 20251230T170808 | Bearish | Relevance: 100%
- Glancy Prongay & Murray LLP is alerting investors of Freeport-McMoran Inc. (FCX) about an upcoming deadline to file a lead plaintiff motion in a class action lawsuit. The lawsuit alleges that Freeport-McMoran made false and misleading statements regarding safety at its Grasberg Block Cave mine in Indonesia, leading to significant stock price drops after a mining incident. Investors who suffered losses between February 15, 2022, and September 24, 2025, are urged to contact the firm.

**4. Deadline Alert: Freeport-McMoran Inc. (FCX) Shareholders**
- Source: GlobeNewswire | 20251230T170144 | Bearish | Relevance: 100%
- Glancy Prongay & Murray LLP reminds Freeport-McMoran Inc. (NYSE: FCX) investors of the January 12, 2026 deadline to file a lead plaintiff motion in a class action lawsuit. This suit alleges that Freeport made misleading statements and failed to disclose safety issues at its Grasberg Block Cave mine, which led to worker fatalities and significant stock price drops between February 15, 2022, and September 24, 2025. Investors who suffered losses are urged to contact the firm.

**5. Freeport-McMoRan (FCX) stock slides as metals retreat from record highs; Fed minutes next**
- Source: ts2.tech | 20251230T020820 | Somewhat-Bearish | Relevance: 100%
- Freeport-McMoRan (FCX) shares slid 2.9% following a sharp pullback in precious metals and copper, which hit record highs earlier. Traders are anticipating the Federal Reserve's December meeting minutes for further macro cues, while year-end thin trading exacerbated the metals' decline. The company's future stock movement is expected to depend more on the direction of metals prices than on company-specific news.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-23 | Wells Fargo | $55 | $47 | +17% |
| 2025-12-12 | UBS | $60 | $55 | +9% |
| 2025-12-05 | JP Morgan | $58 | $50 | +16% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-23 | Wells Fargo | main | Overweight |
| 2025-12-12 | UBS | main | Buy |
| 2025-12-05 | JP Morgan | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($1.82M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.0% (+1.4%)
- Blackrock Inc.: 7.4% (+0.6%)
- Fisher Asset Managem: 4.4% (+1.4%)
- State Street Corpora: 4.3% (+1.1%)
- Capital Research Glo: 2.9% (-31.2%)

### Key Risks

1. Valuation risk: PEG 4.5x with declining EPS estimates leaves no margin for error.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +14%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 4.54 signals overvaluation risk, limited margin of safety. Forward P/E 22.2x attractive for 50% earnings growth. Balance sheet: strong liquidity (2.5x). Analyst sentiment positive (3 raises, avg +14%). Insider selling cluster ($1.8M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $73.8B |
| Beta | 1.48 |
| 52W Range | $27.66 - $53.77 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.54 |
| Forward P/E | 22.2 |
| Current P/E | 33.3 |
| YoY Growth | 49.7% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 11.6% to 7.0% (-4.5% in 5 days), indicating relative weakness vs NASDAQ. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 98th percentile. MRS_5 (-0.5%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 7.2% shows strong absolute momentum above own 20MA. Outperforming sector by 5.1pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 71, risk of mean reversion. OFD pattern: -MLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 7.05% (CS: 99) | Strong |
| RSI_14 | 71.2 | Overbought |
| MACD Histogram | 0.30 | Bullish |
| vs SMA20 | 1.072x | Above |
| vs SMA50 | 1.175x | Above |
| vs SMA200 | 1.240x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $51.42
- **Stop Loss:** $48.42 (5.8% risk)
- **Target:** $55.92 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 440
- **Position Value:** $22,624.80
- **Portfolio %:** 22.62%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-01-22 (Est: $0.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.41 | $0.50 | +22.8% |
| 2025Q2 | $0.44 | $0.54 | +21.8% |
| 2025Q1 | $0.23 | $0.24 | +4.6% |
| 2024Q4 | $0.22 | $0.31 | +43.2% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*